2026 Robert A. Anders: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	103	7151	6714	3756	3475	339	81185

Overview

Robert A. Anders is affiliated with Johns Hopkins University School of Medicine in the United States. Their research spans multiple fields within medical science, with a focus on oncology and related molecular biology disciplines.

The main fields of study in their work include Medicine, with a significant volume of 246 publications, and Biochemistry, Genetics and Molecular Biology, comprising 81 publications.

Their research extends into several subfields, notably Oncology (95 publications), Molecular Biology (37 publications), Immunology (36 publications), Surgery (32 publications), and Hepatology (26 publications).

Main topics covered by Robert A. Anders's work encompass aspects crucial to cancer research and treatment:

Cancer Immunotherapy and Biomarkers
Pancreatic and Hepatic Oncology Research
Cancer Genomics and Diagnostics
Single-cell and spatial transcriptomics
Hepatocellular Carcinoma Treatment and Prognosis
Immunotherapy and Immune Responses
Cholangiocarcinoma and Gallbladder Cancer Studies

Frequent publication venues for their work include:

Journal of Clinical Oncology
Cancer Research
Clinical Cancer Research
bioRxiv (Cold Spring Harbor Laboratory)
Regular and Young Investigator Award Abstracts

Frequent collaborators in their research are:

Qingfeng Zhu
Elizabeth M. Jaffee
Mark Yarchoan
Won Jin Ho
Elana J. Fertig

Selected recent publications by Robert A. Anders highlight ongoing research in clinical oncology and cancer immunotherapy. These include:

Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology, 2021, Journal of the National Comprehensive Cancer Network
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution, 2020, Cell
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity, 2021, Nature Cancer
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade, 2021, Science
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023, 2023, Journal of the National Comprehensive Cancer Network

Best Publications

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Suzanne L. Topalian;F. Stephen Hodi;Julie R. Brahmer;Scott N. Gettinger

14371
Citations
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Dung T. Le;Jennifer N. Uram;Hao Wang;Bjarne R. Bartlett

10084
Citations
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Dung T. Le;Dung T. Le;Jennifer N. Durham;Jennifer N. Durham;Kellie N. Smith;Hao Wang

6773
Citations
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Julie R. Brahmer;Charles G. Drake;Ira Wollner;John D. Powderly

3544
Citations
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

Suzanne L. Topalian;Janis M. Taube;Robert A. Anders;Drew M. Pardoll

2828
Citations
Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

Janis M Taube;Alison P. Klein;Julie R Brahmer;Haiying Xu

2597
Citations
Elucidation of a universal size-control mechanism in Drosophila and mammals.

Jixin Dong;Georg Feldmann;Jianbin Huang;Shian Wu

2535
Citations
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

Janis M. Taube;Robert A. Anders;Geoffrey D. Young;Haiying Xu

2415
Citations
Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Douglas B. Johnson;Justin M. Balko;Margaret L. Compton;Spyridon Chalkias

2293
Citations
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints

Nicolas J. Llosa;Michael Cruise;Ada Tam;Elizabeth C. Wicks

1612
Citations
Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP

Yi Liu-Chittenden;Bo Huang;Joong Sup Shim;Qian Chen

1418
Citations
Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria

Christine M. Dejea;Payam Fathi;John M. Craig;Annemarie Boleij;Annemarie Boleij

877
Citations
The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals

Nailing Zhang;Haibo Bai;Karen K. David;Jixin Dong

830
Citations
A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non–small cell lung cancer

David L. Rimm;Gang Han;Janis M. Taube;Eunhee S. Yi

777
Citations
Expression of Yes-associated protein in common solid tumors

Angela A. Steinhardt;Mariana F. Gayyed;Mariana F. Gayyed;Alison P. Klein;Jixin Dong

677
Citations
Hepatobiliary cancers, Version 2.2021

Al B. Benson;Michael I. D'Angelica;Daniel E. Abbott;Daniel A. Anaya

676
Citations
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

Yuchen Jiao;Timothy M Pawlik;Robert A Anders;Florin M Selaru

672
Citations
Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody

Evan J. Lipson;William H. Sharfman;Charles G. Drake;Ira Wollner

653
Citations
LAG-3 regulates CD8 + T cell accumulation and effector function in murine self- and tumor-tolerance systems

Joseph F. Grosso;Cristin C. Kelleher;Timothy J. Harris;Charles H. Maris

651
Citations
PD-1 blockade in tumors with mismatch repair deficiency.

Dung T. Le;Jennifer N. Uram;Hao Wang;Bjarne Bartlett

64
Citations

Frequent Co-Authors

Janis M. Taube Johns Hopkins University

Timothy M. Pawlik The Ohio State University Wexner Medical Center

Elizabeth M. Jaffee Johns Hopkins University

Suzanne L. Topalian Johns Hopkins University

Franck Housseau Johns Hopkins University School of Medicine

Drew M. Pardoll Johns Hopkins University School of Medicine

Charles G. Drake Columbia University

Luis A. Diaz Memorial Sloan Kettering Cancer Center

Bert Vogelstein Johns Hopkins University

Anirban Maitra The University of Texas MD Anderson Cancer Center

External Links

Personal website of Robert A. Anders

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

If you’re considering a future in healthcare, there are many alternative routes and online degrees that can quickly open doors to rewarding careers. One such pathway is through direct entry msn programs for non nurses online. These programs allow individuals with a non-nursing bachelor’s degree to fast-track their transition into advanced nursing practice without starting from scratch.

For those looking for a streamlined entry into nursing, adn nursing programs offer a practical and quicker alternative to traditional four-year degrees. These programs equip students with fundamental skills and often have more flexible admission requirements.

Beyond direct patient care, medical careers exist in fields like healthcare administration. Accredited medical billing and coding online schools can prepare you for vital back-office roles, which are increasingly in demand as healthcare systems expand and evolve.

Admission exams can be a barrier for some students. Fortunately, there are nursing schools that don’t require teas or hesi, making it easier for aspiring healthcare professionals to get started on their education journey sooner.